BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND MAF, MGC71685, 4094, ENSG00000178573
14 results:

  • 1. Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background.
    Eng ZH; Abdullah MI; Ng KL; Abdul Aziz A; Arba'ie NH; Mat Rashid N; Mat Junit S
    Front Endocrinol (Lausanne); 2022; 13():1039494. PubMed ID: 36686473
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Co-Occurrence of Familial Non-Medullary thyroid cancer (FNMTC) and Hereditary Non-Polyposis Colorectal cancer (HNPCC) Associated Tumors-A Cohort Study.
    Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
    Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
    [TBL] [Abstract] [Full Text] [Related]  

  • 3.
    Orois A; Gara SK; Mora M; Halperin I; Martínez S; Alfayate R; Kebebew E; Oriola J
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31703244
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Expression and function of FRA1 protein in tumors.
    Jiang X; Xie H; Dou Y; Yuan J; Zeng D; Xiao S
    Mol Biol Rep; 2020 Jan; 47(1):737-752. PubMed ID: 31612408
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fabrication and characterization of solid lipid nano-formulation of astraxanthin against DMBA-induced breast cancer via Nrf-2-Keap1 and NF-kB and mTOR/maf-1/PTEN pathway.
    Sun T; Gao J; Han D; Shi H; Liu X
    Drug Deliv; 2019 Dec; 26(1):975-988. PubMed ID: 31556759
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Letter regarding the article: "Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls" by Kern et al.
    Colombo C; Fugazzola L; Muzza M; Proverbio MC; Cirello V
    Eur J Med Genet; 2018 Feb; 61(2):104-105. PubMed ID: 28779995
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls.
    Kern B; Coppin L; Romanet P; Crépin M; Szuster I; Renaud F; Leteurtre E; Frénois F; Wemeau JL; Carnaille B; Cardot-Bauters C; Do Cao C; Pigny P
    Eur J Med Genet; 2017 Mar; 60(3):178-184. PubMed ID: 28089742
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A gene-disease association study of IL18 in thyroid cancer: genotype and haplotype analyses.
    Abdolahi F; Dabbaghmanesh MH; Haghshenas MR; Ghaderi A; Erfani N
    Endocrine; 2015 Dec; 50(3):698-707. PubMed ID: 26041375
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.
    Min XS; Huang P; Liu X; Dong C; Jiang XL; Yuan ZT; Mao LF; Chang S
    Tumour Biol; 2015 Sep; 36(10):7457-63. PubMed ID: 25908172
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Interleukin (IL)-21 promoter polymorphism increases the risk of thyroid cancer in Chinese population.
    Xiao M; Hu S; Tang J; Zhang L; Jiang H
    Gene; 2014 Mar; 537(1):15-9. PubMed ID: 24389496
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical significance of microscopic anaplastic focus in papillary thyroid carcinoma.
    Choi JY; Hwang BH; Jung KC; Min HS; Koo do H; Youn YK; Lee KE
    Surgery; 2013 Jul; 154(1):106-10. PubMed ID: 23809489
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Effect of PTTG on endogenous gene expression in HEK 293 cells.
    Panguluri SK; Kakar SS
    BMC Genomics; 2009 Dec; 10():577. PubMed ID: 19958546
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Improvement of image quality of multislice spiral CT scans of the head and neck region using a raw data-based multidimensional adaptive filtering (maf) technique.
    Baum U; Anders K; Steinbichler G; Lell M; Greess H; Riedel T; Kachelriess M; Kalender WA; Bautz WA
    Eur Radiol; 2004 Oct; 14(10):1873-81. PubMed ID: 15338187
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
    Wasenius VM; Hemmer S; Kettunen E; Knuutila S; Franssila K; Joensuu H
    Clin Cancer Res; 2003 Jan; 9(1):68-75. PubMed ID: 12538453
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.